loadpatents
name:-0.01239013671875
name:-0.005424976348877
name:-0.00041294097900391
Whitehouse; Martha Jo Patent Filings

Whitehouse; Martha Jo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Whitehouse; Martha Jo.The latest application filed is for "method of treating dyspnea associated with acute heart failure".

Company Profile
0.12.21
  • Whitehouse; Martha Jo - San Francisco CA
  • Whitehouse; Martha Jo - San Franicsco CA
  • Whitehouse; Martha Jo - San Mateo CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method of treating dyspnea associated with acute heart failure
App 20170151311 - Unemori; Elaine ;   et al.
2017-06-01
Method of lowering mortality
Grant 9,579,363 - Unemori , et al. February 28, 2
2017-02-28
Method Of Treating Chronic Heart Failure By Administering Relaxin
App 20160287672 - Unemori; Elaine ;   et al.
2016-10-06
Method of lowering mortality
Grant 9,205,132 - Unemori , et al. December 8, 2
2015-12-08
Method of treating dyspnea associated with acute heart failure
App 20150320834 - Unemori; Elaine ;   et al.
2015-11-12
Method of treating neurohormonal imbalance
Grant 9,066,916 - Unemori , et al. June 30, 2
2015-06-30
Angiogenically Effective Unit Dose Of Fgf-2 And Method Of Use
App 20140349932 - Whitehouse; Martha Jo
2014-11-27
Method of treating coronary artery disease FGF-2
Grant 8,796,211 - Whitehouse August 5, 2
2014-08-05
Method Of Treating Chronic Heart Failure By Administering Relaxin
App 20140005112 - Unemori; Elaine ;   et al.
2014-01-02
Method Of Treating Dyspnea Associated With Acute Heart Failure
App 20130210730 - Unemori; Elaine ;   et al.
2013-08-15
Method of treating dyspnea associated with acute heart failure
App 20130116181 - Unemori; Elaine ;   et al.
2013-05-09
Angiogenically Effective Unit Dose Of Fgf-2 And Method Of Use
App 20120289464 - Whitehouse; Martha Jo
2012-11-15
Method Of Treating Dyspnea Associated With Acute Heart Failure
App 20120040902 - Unemori; Elaine ;   et al.
2012-02-16
Method of treating dyspnea associated with acute heart failure
Grant 8,053,411 - Unemori , et al. November 8, 2
2011-11-08
Method of Treating Dyspnea Associated with Acute Heart Failure
App 20100048475 - Unemori; Elaine ;   et al.
2010-02-25
Methods and compositions for the treatment of peripheral artery disease
Grant 7,541,337 - Whitehouse June 2, 2
2009-06-02
Angiogenically effective unit dose of FGF-2 and method of use
Grant 7,541,333 - Whitehouse June 2, 2
2009-06-02
COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER
App 20080242648 - Ordentlich; Peter ;   et al.
2008-10-02
Methods And Compositions For The Treatment Of Peripheral Artery Disease
App 20070135348 - Whitehouse; Martha Jo
2007-06-14
Methods and compositions for the treatment of peripheral artery disease
Grant 7,186,407 - Whitehouse March 6, 2
2007-03-06
Methods and compositions for the treatment of peripheral artery disease
App 20040209817 - Whitehouse, Martha Jo
2004-10-21
Angiogenically effective unit dose of FGF-2 and method of use
App 20030166550 - Whitehouse, Martha Jo
2003-09-04
Angiogenically effective unit dose of FGF-2 and method of use
Grant 6,440,934 - Whitehouse August 27, 2
2002-08-27
Methods and compositions for the treatment of peripheral artery disease
App 20020115603 - Whitehouse, Martha Jo
2002-08-22
Methods and compositions for the treatment and prevention of erectile dysfunction
App 20020032153 - Whitehouse, Martha Jo
2002-03-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed